Physical Therapy and Relaxation Techniques Boost Resilience in Older Lung Cancer Patients
A completed pilot trial tested physical therapy and progressive muscle relaxation to preserve function and mood in older adults with advanced lung cancer.
Summary
Older adults with advanced lung cancer face steep declines in physical function and mood during treatment, threatening their independence and quality of life. This completed pilot trial from Ohio State University tested whether combining physical therapy with progressive muscle relaxation could bolster resilience — the capacity to recover functioning after a health setback — in patients with stage IIIA-B or IV lung cancer. Eighteen participants were enrolled over roughly two years, with the intervention targeting physical performance, symptom burden, and emotional wellbeing. The rationale is that resilience-focused interventions may help older cancer patients maintain independence longer, even amid aggressive treatments. While results are not yet published, the study lays groundwork for integrating structured movement and mind-body techniques into standard oncology care for the elderly.
Detailed Summary
Cancer treatment in older adults presents a paradox: the therapies needed to fight disease can simultaneously accelerate functional decline, erode mood, and strip away independence. For patients with advanced lung cancer, this challenge is especially acute given the aggressive nature of the disease and its treatment. Finding supportive interventions that preserve physical and psychological resilience during active treatment is therefore a meaningful clinical priority.
This pilot clinical trial, sponsored by Ohio State University Comprehensive Cancer Center, enrolled 18 older patients diagnosed with stage IIIA-B or IV lung cancer who were actively undergoing treatment. The intervention paired structured physical therapy with progressive muscle relaxation — a well-established mind-body technique involving systematic tensing and releasing of muscle groups to reduce physiological stress. Researchers assessed outcomes including physical performance, mood, symptom burden, and quality of life via questionnaires and standardized assessments.
The trial was completed in June 2022. No results have been publicly reported in the abstract, which is typical for pilot studies at the registry stage prior to manuscript publication. However, the study's design reflects growing recognition that resilience — defined here as the ability to return to baseline functioning after a stressor like cancer treatment — is a trainable and measurable construct in older oncology populations.
From a clinical standpoint, the findings could support routine incorporation of physical therapy and relaxation-based interventions into geriatric oncology care pathways. Even modest improvements in physical performance and mood during treatment can have downstream effects on treatment tolerance, hospitalization rates, and overall survival in this population.
Several caveats apply. The small enrollment of 18 participants limits statistical power and generalizability. The trial phase is listed as NA, suggesting a feasibility or pilot design rather than a powered efficacy trial. Full interpretation awaits peer-reviewed publication of the results.
Key Findings
- Physical therapy combined with progressive muscle relaxation was studied to improve resilience in older lung cancer patients during active treatment.
- The trial targeted physical performance, mood, and quality of life in patients with stage IIIA-B or IV lung cancer.
- Resilience — returning to normal functioning after treatment-related stressors — was a primary conceptual focus of the intervention.
- The trial completed enrollment of 18 participants and concluded in June 2022; published results are pending.
- The study adds to evidence that non-pharmacological, mind-body approaches may support functional independence in older cancer patients.
Methodology
This was a completed pilot clinical trial (Phase NA) enrolling 18 older adults with advanced lung cancer at Ohio State University Comprehensive Cancer Center. Interventions included structured physical therapy, progressive muscle relaxation, quality-of-life assessments, and questionnaire administration. The trial ran from January 2020 to June 2022.
Study Limitations
The very small sample size of 18 participants significantly limits statistical power and generalizability to broader lung cancer populations. The summary is based on the abstract only, as the full trial results have not been published; actual efficacy data cannot be evaluated. The pilot/Phase NA designation means this trial was not powered to detect definitive treatment effects.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.